Publications
HCCI’s external researcher publications powered by #HCCIdata

Oct
06

Trends in HIV PrEP utilization, spending, and price

Pre-exposure prophylaxis (PrEP) for HIV are medications that reduce an individual's chances of contracting HIV. The CDC estimates that 1.2 million people are at risk of HIV infection and may benefit from a PrEP prescription. We analyzed health insurance claims for 55 million Americans with employer-sponsored insurance in order to examine utilization and spending on these drugs between 2016 and 202...

Continue reading
Oct
04

HCCI Spotlights Breast Cancer Awareness Month: Use of Mammograms Peaks in October

Mammography screenings are recommended every 1-2 years for women aged 40 and older, as well as for younger women who are at high risk for breast cancer. These screenings are an essential tool for early detection and treatment of breast cancer. Using HCCI's data on people with employer-sponsored insurance as well as Medicare and Medicaid data, we examined mammography utilization patterns from 2018 ...

Continue reading
Sep
29

Kaiser Health News: Few Places Have More Medical Debt Than Dallas-Fort Worth, but Hospitals There Are Thriving

HCCI's Healthy Marketplace Index was cited in a KHN article on medical debt in Dallas-Fort Worth.  From the article: "Dallas-Fort Worth has the highest medical prices in Texas, according to the Health Care Cost Institute, a nonprofit that tracks costs nationwide. And in a state where most markets have relatively low medical prices, in-patient care at Dallas-Fort Worth hospitals was 13% more e...

Continue reading
Sep
21

September 2022 HCCI Research Highlights

 HCCI's data users and staff use our multi-payer, longitudinal commercial claims dataset to study some of the most pressing issues in the U.S. health care system. Here we highlight some recent research using HCCI data: New Study Shows Patients Paying More Out-of-Pocket Costs for Cancer Care | American Cancer Society A new, large study led by researchers at the American Cancer Society (ACS) an...

Continue reading
Tags:
Sep
20

Biosimilar Savings among People with Employer-Sponsored Insurance Not Keeping Pace with Savings in Medicare

Biologic drugs include a range of life-saving medications to treat cancer, diabetes, rheumatoid arthritis, retinal diseases, and many other conditions. Unlike "small molecule" drugs (e.g., statins), which can generally be taken at home, biologics are typically infusions or injections which require administration by a physician or other clinician in a hospital or physician's office. While just...

Continue reading